Published in Biomed Res Int on October 28, 2013
Postoperative Albumin Drop Is a Marker for Surgical Stress and a Predictor for Clinical Outcome: A Pilot Study. Gastroenterol Res Pract (2016) 0.90
A Novel Approach to Major Surgery: Tracking Its Pathophysiologic Footprints. World J Surg (2015) 0.79
The Neutrophil to Lymphocyte Ratio on Admission and Short-Term Outcomes in Orthogeriatric Patients. Int J Med Sci (2016) 0.75
Systemic and Local Administration of Antimicrobial and Cell Therapies to Prevent Methicillin-Resistant Staphylococcus epidermidis-Induced Femoral Nonunions in a Rat Model. Mediators Inflamm (2016) 0.75
Predictive value of C-reactive protein in critically ill patients after abdominal surgery. Clinics (Sao Paulo) (2017) 0.75
Correlation of ischemia-modified albumin with SOFA and APACHE II scores in preoperative patients with colorectal cancer. ScientificWorldJournal (2014) 0.75
Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol (2016) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS. J Exp Med (1930) 10.97
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet (2004) 5.49
Sepsis biomarkers: a review. Crit Care (2010) 4.76
Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest (2011) 3.90
C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest (2003) 2.95
Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med (1999) 2.93
Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest (1993) 2.92
Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta (1981) 2.77
Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46
Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J (2006) 2.22
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation (2003) 2.09
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care (2009) 1.93
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res (2005) 1.91
Inflammation, C-reactive protein, and atherothrombosis. J Periodontol (2008) 1.82
Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med (2002) 1.77
Severe sepsis, coagulation, and fibrinolysis: dead end or one way? Crit Care Med (2012) 1.76
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol (2005) 1.67
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res (2005) 1.67
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J (2005) 1.49
C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J (2009) 1.48
C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect (2005) 1.43
Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care (2006) 1.41
Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med (2009) 1.40
Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis (2012) 1.38
C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review. Anaesth Intensive Care (2011) 1.35
Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med (2005) 1.33
Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation (2005) 1.33
Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol (2002) 1.32
C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care (2011) 1.31
Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol (2006) 1.27
C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med (2008) 1.25
Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem (2008) 1.22
Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care (2007) 1.19
C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med (1986) 1.18
Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin (2009) 1.17
Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. J Exp Med (1984) 1.17
Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem (2009) 1.15
Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis (2005) 1.15
C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle (2009) 1.12
Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care (2006) 1.12
Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res (2007) 1.11
C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care (2011) 1.10
Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A (1997) 1.10
Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J (2008) 1.10
C-reactive protein isoforms differ in their effects on thrombus growth. Arterioscler Thromb Vasc Biol (2008) 1.09
C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol (2006) 1.09
Topology and structure of the C1q-binding site on C-reactive protein. J Immunol (2001) 1.08
Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest (2011) 1.03
Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care (2012) 1.00
The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection (2008) 1.00
Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. J Clin Pathol (2006) 0.99
Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest (2009) 0.97
Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. Am J Physiol Heart Circ Physiol (2007) 0.90
Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock (2006) 0.90
Impact of fulminant hepatic failure in C-reactive protein? J Crit Care (2010) 0.89
Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice. J Immunol (2003) 0.89
C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc gamma R on dendritic cells. J Immunol (2007) 0.89
Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. Infection (2008) 0.88
C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion. Brain Res (2011) 0.87
Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis (2007) 0.86
Effect of C-reactive protein on gene expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol (2004) 0.86
Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients? Thromb J (2004) 0.84
Sepsis and cirrhosis: many similarities. Acta Gastroenterol Belg (2011) 0.81
The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission. J Crit Care (2011) 0.78
Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med (2010) 8.58
Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med (2007) 3.06
Use of capillary zone electrophoresis for differentiating excessive from moderate alcohol consumption. Clin Chem (2003) 1.70
Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. Eur Urol (2009) 1.45
Acidic and neutral sialidase in the erythrocytes of patients with Type 2 diabetes: influence on erythrocyte lifespan. Blood (2002) 1.38
End-tidal carbon dioxide and arterial pressure for predicting volume responsiveness by the passive leg raising test: a commentary. Intensive Care Med (2013) 1.07
Exosites mediate the anti-inflammatory effects of a multifunctional serpin from the saliva of the tick Ixodes ricinus. FEBS J (2009) 0.96
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients. Am J Nephrol (2012) 0.90
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm (2013) 0.87
The impact of gene knock-down and vaccination against salivary metalloproteases on blood feeding and egg laying by Ixodes ricinus. Int J Parasitol (2007) 0.86
Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin. Intensive Care Med (2012) 0.86
Assessment of oxidative stress in tumors and histologically normal mucosa from patients with head and neck squamous cell carcinoma: a preliminary study. Eur J Cancer Prev (2013) 0.84
Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patients. Thromb J (2009) 0.82
Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors. J Med Chem (2013) 0.82
Frailty in old age is associated with decreased interleukin-12/23 production in response to toll-like receptor ligation. PLoS One (2013) 0.81
Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors. J Med Chem (2010) 0.81
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. J Med Chem (2012) 0.80
Is the Nociception Coma Scale-Revised a Useful Clinical Tool for Managing Pain in Patients With Disorders of Consciousness? Clin J Pain (2016) 0.80
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. Eur J Pharmacol (2006) 0.78
Alterations of the Erythrocyte Membrane during Sepsis. Crit Care Res Pract (2012) 0.77
Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications. Anal Biochem (2010) 0.77
Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme. Talanta (2007) 0.76
Do you ask your blood banker to transfuse only fresh red blood cells in cardiac patients?*. Crit Care Med (2012) 0.75
Time Course of CD64, a Leukocyte Activation Marker, During Cardiopulmonary Bypass Surgery. Shock (2017) 0.75
Apolipoprotein L Expression Correlates with Neutrophil Cell Death in Critically Ill Patients. Shock (2017) 0.75
Prognostic value of lymph node ratio for locoregional failure in patients with advanced head and neck cancers. Minerva Stomatol (2016) 0.75